Molecule Information
General Information of the Molecule (ID: Mol01144)
Name |
Gamma-glutamylcysteine synthetase (GGCS)
,Plasmodium berghei
|
||||
---|---|---|---|---|---|
Synonyms |
Gamma-ECS
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
ggcs
|
||||
Sequence |
MPALRPALLWALLALWLCCAAPAHALQCRDGYEPCVNEGMCVTYHNGTGYCKCPEGFLGE
YCQHRDPCEKNRCQNGGTCVAQAMLGKATCRCASGFTGEDCQYSTSHPCFVSRPCLNGGT CHMLSRDTYECTCQVGFTGKECQWTDACLSHPCANGSTCTTVANQFSCKCLTGFTGQKCE TDVNECDIPGHCQHGGTCLNLPGSYQCQCPQGFTGQYCDSLYVPCAPSPCVNGGTCRQTG DFTFECNCLPGFEGSTCERNIDDCPNHRCQNGGVCVDGVNTYNCRCPPQWTGQFCTEDVD ECLLQPNACQNGGTCANRNGGYGCVCVNGWSGDDCSENIDDCAFASCTPGSTCIDRVASF SCMCPEGKAGLLCHLDDACISNPCHKGALCDTNPLNGQYICTCPQGYKGADCTEDVDECA MANSNPCEHAGKCVNTDGAFHCECLKGYAGPRCEMDINECHSDPCQNDATCLDKIGGFTC LCMPGFKGVHCELEINECQSNPCVNNGQCVDKVNRFQCLCPPGFTGPVCQIDIDDCSSTP CLNGAKCIDHPNGYECQCATGFTGVLCEENIDNCDPDPCHHGQCQDGIDSYTCICNPGYM GAICSDQIDECYSSPCLNDGRCIDLVNGYQCNCQPGTSGVNCEINFDDCASNPCIHGICM DGINRYSCVCSPGFTGQRCNIDIDECASNPCRKGATCINGVNGFRCICPEGPHHPSCYSQ VNECLSNPCIHGNCTGGLSGYKCLCDAGWVGINCEVDKNECLSNPCQNGGTCDNLVNGYR CTCKKGFKGYNCQVNIDECASNPCLNQGTCFDDISGYTCHCVLPYTGKNCQTVLAPCSPN PCENAAVCKESPNFESYTCLCAPGWQGQRCTIDIDECISKPCMNHGLCHNTQGSYMCECP PGFSGMDCEEDIDDCLANPCQNGGSCMDGVNTFSCLCLPGFTGDKCQTDMNECLSEPCKN GGTCSDYVNSYTCKCQAGFDGVHCENNINECTESSCFNGGTCVDGINSFSCLCPVGFTGS FCLHEINECSSHPCLNEGTCVDGLGTYRCSCPLGYTGKNCQTLVNLCSRSPCKNKGTCVQ KKAESQCLCPSGWAGAYCDVPNVSCDIAASRRGVLVEHLCQHSGVCINAGNTHYCQCPLG YTGSYCEEQLDECASNPCQHGATCSDFIGGYRCECVPGYQGVNCEYEVDECQNQPCQNGG TCIDLVNHFKCSCPPGTRGLLCEENIDDCARGPHCLNGGQCMDRIGGYSCRCLPGFAGER CEGDINECLSNPCSSEGSLDCIQLTNDYLCVCRSAFTGRHCETFVDVCPQMPCLNGGTCA VASNMPDGFICRCPPGFSGARCQSSCGQVKCRKGEQCVHTASGPRCFCPSPRDCESGCAS SPCQHGGSCHPQRQPPYYSCQCAPPFSGSRCELYTAPPSTPPATCLSQYCADKARDGVCD EACNSHACQWDGGDCSLTMENPWANCSSPLPCWDYINNQCDELCNTVECLFDNFECQGNS KTCKYDKYCADHFKDNHCDQGCNSEECGWDGLDCAADQPENLAEGTLVIVVLMPPEQLLQ DARSFLRALGTLLHTNLRIKRDSQGELMVYPYYGEKSAAMKKQRMTRRSLPGEQEQEVAG SKVFLEIDNRQCVQDSDHCFKNTDAAAALLASHAIQGTLSYPLVSVVSESLTPERTQLLY LLAVAVVIILFIILLGVIMAKRKRKHGSLWLPEGFTLRRDASNHKRREPVGQDAVGLKNL SVQVSEANLIGTGTSEHWVDDEGPQPKKVKAEDEALLSEEDDPIDRRPWTQQHLEAADIR RTPSLALTPPQAEQEVDVLDVNVRGPDGCTPLMLASLRGGSSDLSDEDEDAEDSSANIIT DLVYQGASLQAQTDRTGEMALHLAARYSRADAAKRLLDAGADANAQDNMGRCPLHAAVAA DAQGVFQILIRNRVTDLDARMNDGTTPLILAARLAVEGMVAELINCQADVNAVDDHGKSA LHWAAAVNNVEATLLLLKNGANRDMQDNKEETPLFLAAREGSYEAAKILLDHFANRDITD HMDRLPRDVARDRMHHDIVRLLDEYNVTPSPPGTVLTSALSPVICGPNRSFLSLKHTPMG KKSRRPSAKSTMPTSLPNLAKEAKDAKGSRRKKSLSEKVQLSESSVTLSPVDSLESPHTY VSDTTSSPMITSPGILQASPNPMLATAAPPAPVHAQHALSFSNLHEMQPLAHGASTVLPS VSQLLSHHHIVSPGSGSAGSLSRLHPVPVPADWMNRMEVNETQYNEMFGMVLAPAEGTHP GIAPQSRPPEGKHITTPREPLPPMGFLKIGTPLSWEDVQNVKSLIRLYGILQFVHSYKCN KDRKDEHIMFGDEIEYIIIRNDDKLKEASALLCATDLIDEMMNLESGNDCQYGSHWTPEY SSFTIEGTPSVPFKFELNSSYFIEHCMKIRRNKLNNVLSGLRGVQAITLPCYPNVLLNNS LIMAKKINLEKKKKKINKQEIVETSPINYNCIQINKTIHDSESCDENEPRKHISQKNENK NTSNDIISEDVEENKSTHFVSSDFTQQKYDDLLVPDISMDEVDINNRNDPKNDECVEKED ECQCDVANETLGIEEEDNIFISTIKENSIFKCELFKPDITSEYSNSCLVTDMVISPHSRY VTLTKNIRKRRGTKVISFNEIYKDVNTENMDIWKLSLDKNDKRLFKKKLKKTTLDGHLIW NKSMTNEKKKSEKKNKIKNDETELLDKVIKHSLFSNIDDDEDYIYSYNREFIEEYSKKCK NPIKNYVYLDAMFFGMSMCCQQITMSFQTINDAKYVYDQLAVIAPLFLAITACTPYLGGF LTETDARWRVISNSVDCRTEDELSYISKPRYSGISLYISDELPLKKNYYFYNDIDIILNK NVYDKLIKENVDEYLSRHISSLFVRDPIVVFEGSFSEKDITTIQNIMHEKNENINNSKMW SEEEMNKIYLSDDFEFLEDYKEKVLSSHQHFENFQSTNWNSVRFKPPPILDNNYLNGPSS IGWRVEFRTPDIQITDFENASVVALIMTLSKFILKKKLNLYIPMSKLEENLFRSSKRDAI LKEKFYFRNDINYDTCNNEIEEKSIYDIFFNKNNGILYLCSLYIEEQFEQGLISLSAKNK INEYIQFIKLRCKGEICTGASFLRKFILNHSAYEQNSYINNQINYDLCKLISDIGKGEIA PHELLGGFVDPHKERIKNNLRQISKRQYLKSLAYKFISGEDYTQYLLLNEDLKHDKDFFI QNKHTNYEESDEYIDNNMLEFGKKLYQFSATFQLIPKGSIAQPAGAPQPQSTCPPAVAGP LPTMYQIPEMARLPSVAFPTAMMPQQDGQVAQTILPAYHPFPASVGKYPTPPSQHSYASS NAAERTPSHSGHLQGEHPYLTPSPESPDQWSSSSPHSASDWSDVTTSPTPGGAGGGQRGP GTHMSEPPHNNMQVYA Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
DISM: Drug Inactivation by Structure Modification
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Glutathione
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Malaria | [1] | |||
Sensitive Disease | Malaria [ICD-11: 1F45.0] | |||
Sensitive Drug | Glutathione | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Plasmodium berghei ANkA 2.34 | 5823 | ||
Plasmodium berghei pbggcs-ko | 5821 | |||
Plasmodium berghei pbggcs-oe | 5821 | |||
In Vivo Model | Swiss albino CD-1 female mice xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Western blotting analysis | |||
Experiment for Drug Resistance |
In vivo drug suppressive test assay | |||
Mechanism Description | To analyze the role of GSH levels in CQ and ART resistance, we generated transgenic Plasmodium berghei parasites either deficient in or overexpressing the gamma-glutamylcysteine synthetase gene (pbggcs) encoding the rate-limiting enzyme in GSH biosynthesis. These lines produce either lower (pbggcs-ko) or higher (pbggcs-oe) levels of GSH than wild type parasites. Recrudescence assays after the parasites have been exposed to a sub-lethal dose of ART showed that parasites with low levels of GSH are more sensitive to ART tre. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.